Evommune Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Evommune stock has a consensus rating of "Buy" and an average price target of $35.86. The average 1-year stock price forecast is 179.72% higher than the current stock price, while the lowest is $26 (+102.81%) and the highest is $55 (+329.02%).

Price Target: $35.86 (+179.72%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$26	$35.86	$30	$55
Change	+102.81%	+179.72%	+134.01%	+329.02%

Analyst Ratings

The average analyst rating for Evommune stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	7	7	7	8	8	5
Buy	1	1	2	2	2	3
Hold	0	0	0	0	0	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	9	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Maintains $55 → $26	Buy	Maintains	$55 → $26	+102.81%	Jun 30, 2026
Mitchell Kapoor H.C. Wainwright	H.C. Wainwright	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jun 30, 2026
Kaveri Pohlman Clear Street	Clear Street	Buy Maintains $53 → $28	Buy	Maintains	$53 → $28	+118.41%	Jun 29, 2026
Matt Phipps William Blair	William Blair	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jun 29, 2026
Brian Abrahams RBC Capital	RBC Capital	Buy Maintains $50 → $30	Buy	Maintains	$50 → $30	+134.01%	Jun 29, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

4.13M

from 13.00M

-68.27%

from 13.00M

Revenue Next Year

1.25M

from 4.13M

-69.70%

from 4.13M

EPS This Year

-2.79

from -11.22

EPS Next Year

-3.24

from -2.79

Fiscal Year	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	5.00M	7.00M	13.00M	4.13M
Revenue Growth	-	40.00%	85.71%	-68.27%
Gross Profit	5.00M	7.00M	13.00M	4.13M
Gross Margin	100.00%	100.00%	100.00%	100.00%
Operating Income	-37.85M	-70.01M	-81.07M	-109.99M
Net Income	-34.05M	-66.81M	-68.87M	-104.87M
EPS	-	-	-11.22	-2.79
Free Cash Flow	-	-20.45M	-56.17M	-115.00M
No. Analysts	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	25.0M
Avg	4.1M
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	92.3%
Avg	-68.3%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-2.56
Avg	-2.79
Low	-3.30

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-